Cargando…

Low risk of myopericarditis after COVID-19 vaccination in children aged 5-11 years

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163891/ http://dx.doi.org/10.1007/s40278-022-16297-8

Ejemplares similares

COVID-19 VACCINE INDUCED FULMINANT MYOPERICARDITIS
por: Doty, Brandon, et al.
Publicado: (2023)

Acute Myopericarditis after COVID-19 Vaccine in Teenagers
por: Ambati, Shashikanth, et al.
Publicado: (2021)

Myopericarditis after COVID-19 vaccination: unexpected but not unprecedented
por: Ryan, Margaret, et al.
Publicado: (2022)

Myopericarditis After COVID-19 Booster Dose Vaccination
por: Sharff, Katie A., et al.
Publicado: (2022)

Suspected COVID-19–Induced Myopericarditis
por: Okor, Ivana, et al.
Publicado: (2021)

MANAGEMENT OF COVID-19 MYOPERICARDITIS WITH AN IMPELLA CP
por: Wen, Jason, et al.
Publicado: (2021)

RAPID RECOVERY OF COVID-19 RELATED MYOPERICARDITIS
por: Mustafa, Ahmad, et al.
Publicado: (2022)

COVID-19 vaccination for children aged 5–11 years
por: Ladhani, Shamez N
Publicado: (2022)

Transient Myopericarditis Following Vaccination for COVID-19
por: Gill, Jashan, et al.
Publicado: (2022)

COVID‐19 mRNA vaccines and myopericarditis
por: Gnanenthiran, Sonali R., et al.
Publicado: (2022)

A Case of Myopericarditis After the Second Dose of mRNA COVID-19 Vaccine in a Patient With a History of Myopericarditis
por: Fujibayashi, Kosuke, et al.
Publicado: (2022)

Short-Term Outcomes After Myopericarditis Related to COVID-19 Vaccination
por: Pareek, Manan, et al.
Publicado: (2022)

COVID-19 MYOPERICARDITIS- NEW STORMS, NEW NORMS?
por: Badejoko, Solomon O., et al.
Publicado: (2022)

COVID‐19 review shows that benefits of vaccinating children and adolescents appear to outweigh risks of post‐vaccination myopericarditis
por: Morello, Rosa, et al.
Publicado: (2022)

COVID-19 Vaccination-Induced Myopericarditis: An Imager’s Perspective
por: Bews, Hilary, et al.
Publicado: (2022)

COVID-19 Vaccine-Induced Pneumonitis, Myositis and Myopericarditis
por: Farooq, Mariya, et al.
Publicado: (2022)

COVID-19 Vaccines and Myopericarditis: A Nuanced Story
por: Jacobs, Mark, et al.
Publicado: (2022)

A CASE OF MYOPERICARDITIS IN A YOUNG ADULT MALE FOLLOWING MODERNA COVID-19 VACCINATION
por: Kahai, Preet, et al.
Publicado: (2022)

Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age
por: Das, Bibhuti B., et al.
Publicado: (2021)

Incidence of myopericarditis after mRNA COVID-19 vaccination: A meta-analysis with focus on adolescents aged 12–17 years
por: Guo, Bao-Qiang, et al.
Publicado: (2023)

MYOPERICARDITIS AND HEART FAILURE WITH REDUCED EJECTION FRACTION FOLLOWING SECOND DOSE OF MRNA COVID-19 VACCINE
por: Cole, Molly, et al.
Publicado: (2023)

Myopericarditis in a Young Adult Secondary to COVID-19 Vaccination
por: Walters, Corbin G., et al.
Publicado: (2021)

COVID-19 INDUCED MYOPERICARDITIS AND CARDIAC TAMPONADE: A DIAGNOSTIC DILEMMA
por: Ebrahim, Mohammed
Publicado: (2022)

No increased risk for venous thromboembolism after COVID-19 vaccination
Publicado: (2022)

Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents
por: Long, Sarah S.
Publicado: (2021)

Low rate of myocarditis/pericarditis after COVID-19 mRNA vaccines
Publicado: (2022)

Moderna Vaccine Induced Recurrent Myopericarditis
por: Arasaratnam, K.
Publicado: (2022)

Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19
por: Elhouderi, Eiman, et al.
Publicado: (2022)

The incidence of myopericarditis in patients with COVID-19
por: Mostafavi, Atoosa, et al.
Publicado: (2021)

A case of myopericarditis following administration of the Pfizer COVID-19 vaccine
por: Morton, Zoey, et al.
Publicado: (2022)

Covid-19-vaccine-pfizer-biontech: Myopericarditis: 25 case reports
Publicado: (2021)

Focal Myopericarditis Presenting as Acute ST-Elevation Myocardial Infarction
por: Mehta, Jeet J., et al.
Publicado: (2018)

A Nonimmunosuppressant Approach on Asia Psoriasis Subjects: 5-Year Followup and 11-Year Data Analysis
por: Tang, Tony Yuqi
Publicado: (2012)

Decrease in Hospitalizations for Pneumonia in Children under Five Years of Age in an Indian Reservation in Panama after the Introduction of the Heptavalent Pneumococcal Conjugate Vaccine (PCV7)
por: Nieto Guevara, Javier, et al.
Publicado: (2013)

Maternal Attitudes and Intentions About the COVID-19 Vaccine for Children Aged 5–11 Years
por: Limbers, Christine A., et al.
Publicado: (2022)

Parents' reasons to vaccinate their children aged 5–11 years against COVID-19 in Italy
por: Napoli, Annalisa, et al.
Publicado: (2022)

Minimal risk of GBS relapse after Pfizer-BioNTech COVID-19 vaccination
Publicado: (2021)

Cardiac risks higher after COVID-19 infection than mRNA vaccine
Publicado: (2022)

Successful Treatment with Corticosteroids in an 11-Year-Old Patient with Crohn’s Disease and Myopericarditis—Case Report
por: Ryzko, Joanna, et al.
Publicado: (2022)

Covid-19-vaccine-pfizer-biontech: Acute myopericarditis: 2 case reports
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_54vak86p2ejusgap7hj0cf17al